Charles River Laboratories International (MEX:CRL) Current Accrued Expense : MXN3,168 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Charles River Laboratories International Current Accrued Expense?

Charles River Laboratories International's Current Accrued Expense for the quarter that ended in Mar. 2024 was MXN3,168 Mil.

Charles River Laboratories International's quarterly Current Accrued Expense increased from Sep. 2023 (MXN3,450 Mil) to Dec. 2023 (MXN3,867 Mil) but then declined from Dec. 2023 (MXN3,867 Mil) to Mar. 2024 (MXN3,168 Mil).

Charles River Laboratories International's annual Current Accrued Expense declined from Dec. 2021 (MXN4,694 Mil) to Dec. 2022 (MXN4,284 Mil) and declined from Dec. 2022 (MXN4,284 Mil) to Dec. 2023 (MXN3,867 Mil).

Charles River Laboratories International Current Accrued Expense Historical Data

The historical data trend for Charles River Laboratories International's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Current Accrued Expense Chart

Charles River Laboratories International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

2,623.77

2,980.22

4,693.54

4,284.40

3,867.16

Charles River Laboratories International Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															3,990.19	3,783.73	3,450.02	3,867.16	3,168.09

Charles River Laboratories International Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Charles River Laboratories International Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Charles River Laboratories International (MEX:CRL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (MEX:CRL) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

CRL:USA RV6:Germany RV6:Germany

Address

251 Ballardvale Street, Wilmington, MA, USA, 01887

Website

https://www.criver.com

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.